FDA Label for Glycolic 35 / Lactic 45 Combo Peel
View Indications, Usage & Precautions
Glycolic 35 / Lactic 45 Combo Peel Product Label
The following document was submitted to the FDA by the labeler of this product Gazebo Wellness Skin Llc. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.
Dosage & Administration
AHA PEELS work by loosening and gently sloughing off the damaged. unattractive skin cells, while working on the deeper layers of skin to accelerate the skin's natural production of collagen and elastin.
Warnings
DIRECTIONS: Apply the peel to the treatment area. Let stand on skin for 2-10 minutes depending on skin tolerance. Remove peel with copious amount of water. Follow with moisturizer. Note: A stinging sensation may occur. Flakiness may occur for 3-5 days after performing peel. When using this product avoid unnecessary sun exposure and use sunscreen. For external use only.
Inactive Ingredient
Inactive ingredient: Deionized Water.
Indications & Usage
DIRECTIONS: Apply the peel to the treatment area. Let stand on skin for 2-10 minutes depending on skin tolerance. Remove peel with copious amount of water. Follow with moisturizer. Note: A stinging sensation may occur. Flakiness may occur for 3-5 days after performing peel. When using this product avoid unnecessary sun exposure and use sunscreen. For external use only.
Otc - Keep Out Of Reach Of Children
keep out of reach of children
Otc - Purpose
Glycolic Acid 35%
Lactic Acid
45%
Clears Acne & Scars Removes Dead Skin Cells
Smoothes Fine lines & Wrinkles
Distributed By:
Skin Beauty Solutions Elk Grove CA 95759
Otc - Active Ingredient
Active ingredients: MD Grade Glycolic Acid, Lactic Acid.
Package Label.Principal Display Panel
Content of labeling
* Please review the disclaimer below.
